From: Minimizing Risk of Nephrogenic systemic fibrosis in Cardiovascular Magnetic Resonance
Class | Net Charge | Trade Name | Short Names | Log K(therm) | Log K(cond7.4) | Kinetic Stabiltiy |
---|---|---|---|---|---|---|
Linear | Non-ionic | Omniscan | Gadodiamide | 16.9 | 14.9 | Low |
 | Non-ionic | Optimark | Gadoversetamide | 16.8 | 15.0 | Low |
 | Ionic | Magnevist | Gadopentetate | 22.5 | 18.4 | Medium |
 | Ionic | Multihance | Gadobenate | 22.6 | 18.4 | Medium |
 | Ionic | Primovist | Gadoxetate | 23.5 | 18.7 | Medium |
 | Ionic | Vasovist | Gadofosvescet | 22.1 | 18.9 | Medium |
Macrocyclic | Non-ionic | Gadovist | Gadobutrol | 21.8 | 15.5 | High |
 | Non-ionic | Prohance | Gadoteridol | 23.8 | 17.2 | High |
 | Ionic | Dotarem | Gadoterate | 25.6 | 19.3 | High |